News Formal

Biopharma company Alvotech to go public in $2.25 bln SPAC deal

  • 📰 Reuters
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 97%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Biopharmaceutical company Alvotech Holdings SA said on Tuesday it plans to list in New York by merging with a blank-check company backed by Oaktree Capital Management, in a deal that values the combined entity at around $2.25 billion.

The Iceland-based company will receive gross proceeds of $450 million from the deal, including $150 million from a private placement in public equity backed by Temasek, CVC Capital Partners and funds managed by Suvretta Capital among others., a special purpose acquisition company , raised $225 million through an initial public offering in September last year.A SPAC is a listed shell company that merges with a private entity to take it public by sidestepping a traditional IPO.

The drugmaker has partnered with pharmaceutical companies in 60 countries and counts Teva Pharmaceutical Industries LtdThe company said it has received license fee commitments of up to $1.15 billion under these partnerships, about 80% of the amount is still to be collected.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

via 5 dollar bills?

अपस्टॉक्स भारत के सबसे तेजी से बढ़ते ब्रोकर में से एक है। पेपरलेस अकाउंट खोलने के साथ एक तेज़, विश्वसनीय और उपयोग करने में आसान ट्रेडिंग प्लेटफॉर्म। अभी अपना डीमैट अकाउंट खोलें! 20/ order anyone segments delivery free

$NVAX nvax Novavax novavax UP 26% 🤑 CNBC

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 2. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Tech IPOs have been a bad bet in 2021 — all but one are in bear market territoryOf the more than 50 U.S. tech companies to go public this year through an IPO, SPAC or direct listing, only one of them is less than 20% off its high price. ESG blockchain revolution - technological, social, evolutionary: transformation scheme based on the example of the carbon credits market
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »

Known For Its Startup Data, Crunchbase's Software Business Is Quietly Making MillionsThe startup expects 80 million visitors to its website next year but the enterprise software it's been building has it on track to record $38 million in ARR this year. diversity tracking metrics and trends - I will do no business with them. $NVAX 17% novavax NVAX Novavax Reddit wallstreetbets wsbmod RobinhoodApp
출처: Forbes - 🏆 394. / 53 더 많은 것을 읽으십시오 »

Najafi Companies Reaches Deal to Buy STX, Ending Merger With ErosThe troubled marriage between STX Entertainment and Eros is dissolving. The Najafi Companies announced Tuesday that it has reached an agreement to acquire the studio behind “Bad Moms” a…
출처: Variety - 🏆 108. / 63 더 많은 것을 읽으십시오 »